News

Seminar presented by Dr. James P. Piret

Dr. James M. Piret from University of British Columbia will held a seminar at McGill University.
This seminar is titled “Acoustic cell washing and Raman spectroscopy technologies to adress cell therapy bioprocess challenges”.

 

2019, November 7th, 9:00AM
MacDonald 267
McGill University, Montreal, QC

 

Details

November 1, 2019

ESACT course on cell culture-based viral vaccines

ESACT (European Society for Animal Cell Technology) offers an introductive course on cell culture-produced viral vaccines. This course will take place in Llafranc, Spain, from 2019, September 29th to October 3rd.

 

This course in designed as an introduction to the production principles of viral vaccines. It will also give an overview of the strategies to respond to the challenges of viral infectious diseases.

 

 

More details on this course here.

 

Grants can be provided to cover the course fee.

August 27, 2019

ESACT animal cell technology course

The 9th edition of ESACT (European Society Animal Cell Technology) animal cell technology course will take place in Llafranc, Spain, on September 22-26, 2019.

This intensive course will provide an overview of the field, from basic notions to pharmaceutical applications.

Details on this course can be found here.

Grants can be provided to cover the course fee.

August 27, 2019

ESACT drug discovery course

The 4th edition of ESACT (European Society Animal Cell Technology) drug delivery course will take place in Llafranc, Spain, from 2019, September 26th to October 3rd.

 

This intensive course will provide an overview of the field, from basic notions to pharmaceutical applications.

 

Details on this course can be found here.

 

Grants can be provided to cover the course fee.

August 27, 2019

Case study: Optimizing Bioassays for Biologics

A case study on bioassays developement, entitled “Optimizing Bioassays for Biologics“, will happen during the “Immunogenicity and Bioassay Summit“.

 

The activity will take place on October 17-18, 2019, in Washington, DC.